Evidence map›Paper›PMID 41990487›Full record

ReviewClinics (Sao Paulo, Brazil)2026

Lung cancer diagnosis from CT scans using artificial intelligence techniques: A global perspective.

Yuanyuan Wang, Weihong Liu, Yongzhong Cao, Fangxing Chen

Abstract readReview
In one paragraph

Review in Clinics (Sao Paulo, Brazil), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yuanyuan WangDepartment of Radiology, CR&WISCO General Hospital, Wuhan, Hubei, China.
Weihong LiuDepartment of Radiology, CR&WISCO General Hospital, Wuhan, Hubei, China.
Yongzhong CaoDepartment of Radiology, CR&WISCO General Hospital, Wuhan, Hubei, China.
Fangxing ChenDepartment of Radiology, CR&WISCO General Hospital, Wuhan, Hubei, China. Electronic address: rrmonkey0122@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIn this research, we conducted a systematic review of artificial intelligence techniques used for the diagnosis of lung cancer.

methodsA systematic search of Web of Science, PubMed, Scopus, Epistemonikos, Cochrane, Medline, and Embase databases was carried out, containing the literature published up to June 2025. Prediction model risk of bias assessment tool (PROBAST) was used to evaluate the risk of bias and applicability of the diagnostic model studies included in the current research.

results204 studies were included. The included articles utilized various AI techniques, including CNN (Convolutional Neural Network), SVM (Support Vector Machine), RF (Random Forest), KNN (K-Nearest Neighbor), PM-DL (Pattern Matching combined with Deep Learning), ANN (Artificial Neural Network), DNN (Deep Neural Network), CDNs (Convolutional Dense Networks), DLS (Deep Learning System), LSTM (Long Short-Term Memory), NNE (Neural Network Ensemble), and LDA (Linear Discriminant Analysis). The CNN model appears to be the most commonly used model in the papers. It was observed that applying deep learning models to preprocessed and augmented medical images led to improved performance metrics, including AUC, sensitivity, and accuracy. The accuracy of artificial intelligence techniques ranged from 68.4 to 100, while the sensitivity varied from 50.0 to 100. The specificity of the artificial intelligence techniques ranged from 50.0 to 100. The AUC of the artificial intelligence techniques ranged from 61.0 % to 100 %, while the recall varied from 75.0 to 99.82.

conclusionThis research accentuates the potential of artificial intelligence techniques in the diagnosis and detection of lung cancer, with diverse levels of diagnostic accuracy. Additional research is required to optimize these artificial intelligence techniques, as well as to ascertain their clinical relevance and appropriateness in real-world clinical applicability.

Indexed as

Artificial intelligenceComputed tomographyDiagnostic accuracyLung cancer

Identifiers

PMID41990487
PMCPMC13094484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.